TopgOptions

NRSN Remember that low liquidity IPO?

Long
NASDAQ:NRSN   NeuroSense Therapeutics Ltd.
For those of you who haven`t bought the NRSN IPO, the chart went exactly like this:

after NeuroSense Therapeutics Received FDA Clearance of IND for PrimeC for the Treatment of ALS today!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.